Apyx Medical Corporation
APYX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,559 | -$18,850 | -$23,278 | -$15,200 |
| Dep. & Amort. | $599 | $692 | $890 | $903 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,013 | $5,114 | $6,697 | $5,088 |
| Change in WC | -$1,245 | $5,543 | -$5,217 | -$1,843 |
| Other Non-Cash | $2,145 | $2,252 | $628 | $603 |
| Operating Cash Flow | -$18,047 | -$5,249 | -$20,280 | -$10,449 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$722 | -$533 | -$1,010 | -$723 |
| Net Acquisitions | $0 | $7,414 | $0 | $195 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$147 | $0 | -$195 |
| Investing Cash Flow | -$722 | $6,734 | -$1,010 | -$723 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$20 | $35,039 | -$148 | -$238 |
| Stock Issued | $7,000 | $2,718 | $365 | $67 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$235 | -$5,591 | $0 | $195 |
| Financing Cash Flow | $6,745 | $32,166 | $217 | $24 |
| Forex Effect | $113 | -$191 | $395 | $103 |
| Net Chg. in Cash | -$11,911 | $33,460 | -$20,678 | -$11,045 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43,652 | $10,192 | $30,870 | $41,915 |
| End Cash | $31,741 | $43,652 | $10,192 | $30,870 |
| Free Cash Flow | -$18,769 | -$5,782 | -$21,290 | -$11,172 |